These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9690814)

  • 1. Ubiquitin, E6-AP, and their role in p53 inactivation.
    Scheffner M
    Pharmacol Ther; 1998 Jun; 78(3):129-39. PubMed ID: 9690814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo ubiquitination and proteasome-mediated degradation of p53(1).
    Maki CG; Huibregtse JM; Howley PM
    Cancer Res; 1996 Jun; 56(11):2649-54. PubMed ID: 8653711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete reconstitution of conjugation and subsequent degradation of the tumor suppressor protein p53 by purified components of the ubiquitin proteolytic system.
    Shkedy D; Gonen H; Bercovich B; Ciechanover A
    FEBS Lett; 1994 Jul; 348(2):126-30. PubMed ID: 8034027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Human diseases associated with ubiquitin/proteasome proteolytic system].
    Anan T; Nakao M
    Tanpakushitsu Kakusan Koso; 1999 May; 44(6):776-86. PubMed ID: 10341550
    [No Abstract]   [Full Text] [Related]  

  • 5. Modes of regulation of ubiquitin-mediated protein degradation.
    Kornitzer D; Ciechanover A
    J Cell Physiol; 2000 Jan; 182(1):1-11. PubMed ID: 10567911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: identification and characterization of the conjugating enzymes.
    Stancovski I; Gonen H; Orian A; Schwartz AL; Ciechanover A
    Mol Cell Biol; 1995 Dec; 15(12):7106-16. PubMed ID: 8524278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway.
    Chang YC; Lee YS; Tejima T; Tanaka K; Omura S; Heintz NH; Mitsui Y; Magae J
    Cell Growth Differ; 1998 Jan; 9(1):79-84. PubMed ID: 9438391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin junction, what's your function?
    Lee TA; Tyers M
    Genome Biol; 2001; 2(10):REPORTS4025. PubMed ID: 11597332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system.
    Scheffner M; Whitaker NJ
    Semin Cancer Biol; 2003 Feb; 13(1):59-67. PubMed ID: 12507557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ubiquitin system.
    Hershko A; Ciechanover A
    Annu Rev Biochem; 1998; 67():425-79. PubMed ID: 9759494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Regulation of cell division by ubiquitin-dependent proteolysis and spindle assembly checkpoint].
    Kazuo T
    Tanpakushitsu Kakusan Koso; 1999 Mar; 44(3):253-62. PubMed ID: 10097657
    [No Abstract]   [Full Text] [Related]  

  • 12. Degradation of human Aurora2 protein kinase by the anaphase-promoting complex-ubiquitin-proteasome pathway.
    Honda K; Mihara H; Kato Y; Yamaguchi A; Tanaka H; Yasuda H; Furukawa K; Urano T
    Oncogene; 2000 Jun; 19(24):2812-9. PubMed ID: 10851084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells.
    Fukazawa T; Fujiwara T; Uno F; Teraishi F; Kadowaki Y; Itoshima T; Takata Y; Kagawa S; Roth JA; Tschopp J; Tanaka N
    Oncogene; 2001 Aug; 20(37):5225-31. PubMed ID: 11526513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geldanamycin-stimulated destabilization of mutated p53 is mediated by the proteasome in vivo.
    Whitesell L; Sutphin P; An WG; Schulte T; Blagosklonny MV; Neckers L
    Oncogene; 1997 Jun; 14(23):2809-16. PubMed ID: 9190897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitin-mediated protein modification and degradation.
    Schwartz AL; Ciechanover A
    Am J Respir Cell Mol Biol; 1992 Nov; 7(5):463-8. PubMed ID: 1329865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ubiquitin-proteasome pathway.
    Roos-Mattjus P; Sistonen L
    Ann Med; 2004; 36(4):285-95. PubMed ID: 15224655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deregulation of the ubiquitin system and p53 proteolysis modify the apoptotic response in B-CLL lymphocytes.
    Masdehors P; Merle-Béral H; Maloum K; Omura S; Magdelénat H; Delic J
    Blood; 2000 Jul; 96(1):269-74. PubMed ID: 10891461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities.
    Kehmeier E; Rühl H; Voland B; Stöppler MC; Androphy E; Stöppler H
    Virology; 2002 Jul; 299(1):72-87. PubMed ID: 12167343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of p53 by adenovirus E1A occurs through its amino-terminal region by modification of the ubiquitin-proteasome pathway.
    Nakajima T; Morita K; Tsunoda H; Imajoh-Ohmi S; Tanaka H; Yasuda H; Oda K
    J Biol Chem; 1998 Aug; 273(32):20036-45. PubMed ID: 9685342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The ubiquitin-ligating system: from the discovery to the present].
    Tanaka K
    Tanpakushitsu Kakusan Koso; 1999 May; 44(6):737-43. PubMed ID: 10341545
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.